EAM
WGSWW

Exos Asset Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Exos Asset Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,000
Closed -$14K – 459
2020
Q4 		$14K Buy
+5,000
New +$12.6K 0.02% 214

Other funds holding WGSWW

SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Exos Asset Management's WGSWW Position: Q1 2021 in Review

Exos Asset Management sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2021, closing a stake of 5,000 shares — an estimated $14K sold.

Exos Asset Management first reported a position in WGSWW in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 28 funds tracked by Wall St. Rank hold WGSWW as of Q1 2021.

  • Exos Asset Management reported no remaining GeneDx Holdings Warrant position as of Q1 2021 after selling out during the quarter.
  • Exos Asset Management sold 5,000 GeneDx Holdings Warrant shares in Q1 2021, an estimated $14K.
  • Exos Asset Management first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 1 quarter.
  • Exos Asset Management's GeneDx Holdings Warrant position peaked at $14K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2021.

Based on Exos Asset Management's 13F filing for Q1 2021, filed 5 May 2021.